| Product Code: ETC8837629 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Choroidal neovascularization, often linked with age-related macular degeneration (AMD), is a significant concern in ophthalmology. Anti-VEGF therapies and laser treatments are key components of the market, driven by aging demographics and expanding eye care facilities in major Philippine cities.
The Philippines choroidal neovascularization (CNV) market is experiencing growth due to an increasing awareness of retinal diseases and the rise in the aging population. CNV is a condition that affects the eye and can lead to severe vision impairment if untreated. The market is driven by the demand for innovative treatments and therapies, particularly anti-VEGF (vascular endothelial growth factor) drugs, which have been shown to reduce CNV-related vision loss. Furthermore, advancements in diagnostic technologies, such as OCT (optical coherence tomography), are contributing to earlier detection and better management of the condition. As the healthcare system in the Philippines continues to improve, the demand for CNV treatments and associated products is expected to rise.
Choroidal Neovascularization, often associated with age-related macular degeneration, presents market challenges such as low awareness of retinal diseases, limited access to ophthalmologic specialists, and the high cost of anti-VEGF therapies. Public health initiatives for early diagnosis are insufficient, leading to vision loss in many untreated patients.
The Philippines Choroidal Neovascularization (CNV) Market presents significant opportunities due to the increasing prevalence of retinal diseases associated with aging and diabetes. CNV is a major cause of vision loss in conditions like age-related macular degeneration (AMD). As the healthcare sector in the Philippines continues to improve, there is a growing demand for advanced therapies, such as anti-VEGF injections, that can effectively treat CNV. Investors can capitalize on the rising awareness and demand for innovative treatments by partnering with pharmaceutical companies, developing local distribution networks, and contributing to research and development efforts for new therapies in the ophthalmology space.
In the Philippines, the government, through the Department of Health (DOH) and the Food and Drug Administration (FDA), regulates the treatments available for choroidal neovascularization (CNV), a condition that affects vision. Policies focus on ensuring that patients have access to effective treatments, including anti-VEGF injections. The government also supports research into new therapies and promotes access to specialized care for patients suffering from vision-threatening conditions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Choroidal Neovascularization Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Choroidal Neovascularization Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Choroidal Neovascularization Market - Industry Life Cycle |
3.4 Philippines Choroidal Neovascularization Market - Porter's Five Forces |
3.5 Philippines Choroidal Neovascularization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Philippines Choroidal Neovascularization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Philippines Choroidal Neovascularization Market Revenues & Volume Share, By Type of Diagnosis, 2021 & 2031F |
3.8 Philippines Choroidal Neovascularization Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Philippines Choroidal Neovascularization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of choroidal neovascularization in the Philippines |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Advances in medical technology and treatment options for choroidal neovascularization |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities in certain regions of the Philippines |
4.3.2 High treatment costs associated with choroidal neovascularization management |
4.3.3 Lack of skilled healthcare professionals trained in diagnosing and treating choroidal neovascularization |
5 Philippines Choroidal Neovascularization Market Trends |
6 Philippines Choroidal Neovascularization Market, By Types |
6.1 Philippines Choroidal Neovascularization Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Philippines Choroidal Neovascularization Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Philippines Choroidal Neovascularization Market Revenues & Volume, By Extreme Myopia, 2021- 2031F |
6.1.4 Philippines Choroidal Neovascularization Market Revenues & Volume, By Malignant Myopic Degeneration, 2021- 2031F |
6.1.5 Philippines Choroidal Neovascularization Market Revenues & Volume, By Age-Related Developments, 2021- 2031F |
6.2 Philippines Choroidal Neovascularization Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Choroidal Neovascularization Market Revenues & Volume, By Extreme Myopia, 2021- 2031F |
6.2.3 Philippines Choroidal Neovascularization Market Revenues & Volume, By Malignant Myopic Degeneration, 2021- 2031F |
6.2.4 Philippines Choroidal Neovascularization Market Revenues & Volume, By Age-Related Developments, 2021- 2031F |
6.3 Philippines Choroidal Neovascularization Market, By Type of Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Philippines Choroidal Neovascularization Market Revenues & Volume, By Fluorescein Angiography (FA), 2021- 2031F |
6.3.3 Philippines Choroidal Neovascularization Market Revenues & Volume, By Indocyanine Green (ICG) Angiography, 2021- 2031F |
6.3.4 Philippines Choroidal Neovascularization Market Revenues & Volume, By Spectral Domain Optical Coherence Tomography (OCT), 2021- 2031F |
6.3.5 Philippines Choroidal Neovascularization Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Choroidal Neovascularization Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 Philippines Choroidal Neovascularization Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 Philippines Choroidal Neovascularization Market Revenues & Volume, By Intravitreal, 2021- 2031F |
7 Philippines Choroidal Neovascularization Market Import-Export Trade Statistics |
7.1 Philippines Choroidal Neovascularization Market Export to Major Countries |
7.2 Philippines Choroidal Neovascularization Market Imports from Major Countries |
8 Philippines Choroidal Neovascularization Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for choroidal neovascularization patients in the Philippines |
8.2 Number of ophthalmologists specializing in choroidal neovascularization treatment per capita in the Philippines |
8.3 Rate of adoption of new treatment modalities for choroidal neovascularization in the Philippines |
9 Philippines Choroidal Neovascularization Market - Opportunity Assessment |
9.1 Philippines Choroidal Neovascularization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Philippines Choroidal Neovascularization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Philippines Choroidal Neovascularization Market Opportunity Assessment, By Type of Diagnosis, 2021 & 2031F |
9.4 Philippines Choroidal Neovascularization Market Opportunity Assessment, By Type, 2021 & 2031F |
10 Philippines Choroidal Neovascularization Market - Competitive Landscape |
10.1 Philippines Choroidal Neovascularization Market Revenue Share, By Companies, 2024 |
10.2 Philippines Choroidal Neovascularization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here